國立虎尾科技大學 |

Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women : = A Program Evaluation Project.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women :/
Reminder of title:	A Program Evaluation Project.
Author:	Lucas, Kathryn A.
Description:	1 online resource (194 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 85-06, Section: B.
Contained By:	Dissertations Abstracts International85-06B.
Subject:	Obstetrics. -
Online resource:	click for full text (PQDT)
ISBN:	9798381164473

Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women : = A Program Evaluation Project.
Lucas, Kathryn A.

Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women :A Program Evaluation Project. - 1 online resource (194 pages)

Source: Dissertations Abstracts International, Volume: 85-06, Section: B.

Thesis (D.N.P.)--The Catholic University of America, 2024.

Includes bibliographical references

Preeclampsia disproportionately affects American Indian and Alaska Native (AIAN) women, who face a twofold higher maternal death risk than White women in the United States. The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin prophylaxis (LDAP) for preeclampsia and related perinatal mortality risk reduction (Grade B) in pregnancies with relevant risk factors as outlined in their clinical guidance table. This project focused on a Navajo tribal facility prenatal clinic with a high preeclampsia rate. In 2020, the clinic adopted LDAP clinical guidelines per the American College of Obstetricians and Gynecologists (ACOG) based on USPSTF 2014 recommendations. A 2021 USPSTF update since broadened consideration of LDAP for women facing societal inequities, and ACOG concurred, additionally stating that universal LDAP may be medically reasonable for high-risk practices in which most patients would be LDAP candidates. Methods: A retrospective chart review assessed AIAN pregnancies (June 2020 - October 2022), using the Promoting Action on Research Implementation in Health Services (PARIHS) Framework to evaluate LDAP implementation. Data gathered on preeclampsia risk factors, delivery demographics, LDAP prescription and LDAP retrieval underwent univariate and bivariate analyses to provide insights from which future revisions to the local LDAP guideline and implementation efforts can be considered. Results: Most patients (81.2%) were LDAP candidates by 2014 criteria. Only 47.3% of candidates retrieved adequate supply; 31.9% of those who had it prescribed did not retrieve adequate supply and 20.8% were not prescribed LDAP. By the expanded 2021 USPSTF criteria, 93.6% would be LDAP candidates. Preeclampsia was diagnosed in 22.0% of the pregnancies. Optimizing LDAP in this AIAN clinic population could avert cases and costs totaling nearly $150,000 by national preeclampsia cost estimates. Significance: The project highlights suboptimal provision and retrieval of LDAP, and an exceedingly high preeclampsia rate among AIAN patients at this rural Navajo tribal facility prenatal clinic. Findings inform potential local LDAP guideline revisions to enhance preeclampsia prevention efforts and maternal health outcomes in this high-risk AIAN clinic population.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798381164473Subjects--Topical Terms:

674110
Obstetrics.
Subjects--Index Terms:

American IndiansIndex Terms--Genre/Form:

554714
Electronic books.

Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women : = A Program Evaluation Project.
LDR:03761ntm a22004337 4500 001 1149392
005 20241015112539.5
006 m o d
007 cr bn ---uuuuu
008 250605s2024 xx obm 000 0 eng d
020 $a 9798381164473
035 $a (MiAaPQ)AAI30696131
035 $a AAI30696131
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Lucas, Kathryn A. $3 1475604
245 1 0 $a Screening for Prevention of Preeclampsia with Low-Dose Aspirin in Navajo Women : $b A Program Evaluation Project.
264 0 $c 2024
300 $a 1 online resource (194 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-06, Section: B.
500 $a Advisor: Robert, Rebecca C.
502 $a Thesis (D.N.P.)--The Catholic University of America, 2024.
504 $a Includes bibliographical references
520 $a Preeclampsia disproportionately affects American Indian and Alaska Native (AIAN) women, who face a twofold higher maternal death risk than White women in the United States. The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin prophylaxis (LDAP) for preeclampsia and related perinatal mortality risk reduction (Grade B) in pregnancies with relevant risk factors as outlined in their clinical guidance table. This project focused on a Navajo tribal facility prenatal clinic with a high preeclampsia rate. In 2020, the clinic adopted LDAP clinical guidelines per the American College of Obstetricians and Gynecologists (ACOG) based on USPSTF 2014 recommendations. A 2021 USPSTF update since broadened consideration of LDAP for women facing societal inequities, and ACOG concurred, additionally stating that universal LDAP may be medically reasonable for high-risk practices in which most patients would be LDAP candidates. Methods: A retrospective chart review assessed AIAN pregnancies (June 2020 - October 2022), using the Promoting Action on Research Implementation in Health Services (PARIHS) Framework to evaluate LDAP implementation. Data gathered on preeclampsia risk factors, delivery demographics, LDAP prescription and LDAP retrieval underwent univariate and bivariate analyses to provide insights from which future revisions to the local LDAP guideline and implementation efforts can be considered. Results: Most patients (81.2%) were LDAP candidates by 2014 criteria. Only 47.3% of candidates retrieved adequate supply; 31.9% of those who had it prescribed did not retrieve adequate supply and 20.8% were not prescribed LDAP. By the expanded 2021 USPSTF criteria, 93.6% would be LDAP candidates. Preeclampsia was diagnosed in 22.0% of the pregnancies. Optimizing LDAP in this AIAN clinic population could avert cases and costs totaling nearly $150,000 by national preeclampsia cost estimates. Significance: The project highlights suboptimal provision and retrieval of LDAP, and an exceedingly high preeclampsia rate among AIAN patients at this rural Navajo tribal facility prenatal clinic. Findings inform potential local LDAP guideline revisions to enhance preeclampsia prevention efforts and maternal health outcomes in this high-risk AIAN clinic population.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Obstetrics. $3 674110
650 4 $a Nursing. $3 563081
650 4 $a Native American studies. $3 1179522
650 4 $a Womens studies. $3 1372829
650 4 $a Ethnic studies. $2 bicssc $3 809601
653 $a American Indians
653 $a Aspirin
653 $a Navajo
653 $a Preeclampsia
653 $a Pregnancy
653 $a Alaska Natives
655 7 $a Electronic books. $2 local $3 554714
690 $a 0380
690 $a 0569
690 $a 0740
690 $a 0631
690 $a 0453
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a The Catholic University of America. $b Nursing. $3 1469514
773 0 $t Dissertations Abstracts International $g 85-06B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30696131 $z click for full text (PQDT)